Nanologica AB (publ) (FRA:4YD)
Germany · Delayed Price · Currency is EUR 0.0650
0.00 (0.00%)
Last updated: Nov 28, 2025, 8:05 AM CET
Nanologica AB Company Description
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces.
The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity.
Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Nanologica AB (publ)
| Country | Sweden |
| Founded | 2004 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 16 |
| CEO | Andreas Bhagwani |
Contact Details
Address: Forskargatan 20 G Södertälje, 151 36 Sweden | |
| Phone | 46 8 41 07 49 49 |
| Website | nanologica.com |
Stock Details
| Ticker Symbol | 4YD |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Andreas Bhagwani | Chief Executive Officer |
| Eva Osterman | Chief Financial Officer |
| Åsa Bergström | Chief Operating Officer |
| Johanna Johansson | Head of Investor Relations |